Trial Profile
A Multi-Center, Active-Controlled, Open-Label, Phase II Trial to Compare the Efficacy and Safety for Treatment of Autologous Chondrocytes Implantation with CartiLife versus Microfracture for Patient with Chondral Defects in the Knee
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors Biosolution
- 22 May 2018 Status changed from recruiting to completed.
- 12 Jan 2016 New trial record